"Rags-To-Riches" Portfolio Update: Week Ending January 20, 2023
The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible and, after such massive declines, the market could well offer high returns to investors in 2023 and beyond and, to that end, I have created a basket of 14 stocks - aptly named the Rags-to-Riches Portfolio - for 2023 with market capitalizations of at least $400M, and trading for at least $1/share. Their performances last week and year-to-date are as follows:
- American Cannabis MSOs:
- Cresco (CRLBF): Y/E 2022 Mkt. Cap.: $1.010M; Y/E Stock Price: $1.75; 2022 Performance: -73.8%
- Last week: -0.5%; +11.4% YTD
- Curaleaf (CURLF): Y/E 2022 Mkt. Cap.: $3,280M; Y/E Stock Price: $3.91; 2022 Performance: -73.8%
- Last week: +1.5%; +3.8% YTD
- Green Thumb (GTBIF): Y/E 2022 Mkt. Cap.: $2,290M; Y/E Stock Price: $8.43; 2022 Performance: -62.0%
- Last week: -3.6%; -5.1% YTD
- TerrAscend (TRSSF): Y/E 2022 Mkt. Cap.: $540M; Y/E Stock Price: $1.10 ; 2022 Performance: -82.0%
- Last week: -9.3%; +23.6% YTD
- Trulieve (TCNNF): Y/E 2022 Mkt. Cap.: $1,770M; Y/E Stock Price: $7.56; 2022 Performance: -70.9%
- Last week: -5.8%; -9.7% YTD
- Verano (VRNOF): Y/E 2022 Mkt. Cap.: $1,190M; Y/E Stock Price: $3.08 ; 2022 Performance: -75.5%
- Last week: +2.0%; -0.6% YTD
- Cresco (CRLBF): Y/E 2022 Mkt. Cap.: $1.010M; Y/E Stock Price: $1.75; 2022 Performance: -73.8%
Sub-total: Last week: -2.9%; -2.2% YTD
- Canadian Cannabis LPs
- Canopy Growth (CGC): Y/E 2022 Mkt. Cap.: $1,380M; Y/E Stock Price: $2.27; 2022 Performance: -74.0%
- Last week: +0.4%; +15.0% YTD
- Cronos (CRON): Y/E 2022 Mkt. Cap: $1,060M; Y/E Stock Price: $2.52; 2022 Performance: -35.7%
- Last week: -1.6%; -0.8% YTD
- Tilray (TLRY): Y/E 2022 Mkt. Cap.: $2,070M; Y/E Stock Price: $2.67; 2022 Performance: -62.0%
- Last week: -4.1%; +14.2% YTD
- Canopy Growth (CGC): Y/E 2022 Mkt. Cap.: $1,380M; Y/E Stock Price: $2.27; 2022 Performance: -74.0%
Sub-total: Last week: -1.9%; +9.4% YTD
- Psychedelic Drug Stocks
- Atai (ATAI): Y/E 2022 Mkt. Cap.: $500M; Y/E Stock Price: $2.58; 2022 Performance: -66.2%
- Last week: +5.6%; -26.4% YTD
- Compass Pathways (CMPS): Y/E 2022 Mkt. Cap.: $402M; Y/E Stock Price: $7.81; 2022 Performance: -64.7%
- Last week: +3.6%; +26.5% YTD
- GH Research (GHRS): Y/E 2022 Mkt. Cap.: $611M; Y/E Stock Price: $9.54; 2022 Performance: -59.1%
- Last week: +1.3%; +2.6% YTD
- Atai (ATAI): Y/E 2022 Mkt. Cap.: $500M; Y/E Stock Price: $2.58; 2022 Performance: -66.2%
Sub-total: Last week: +2.7%; +8.2% YTD
- Plant-Based Food Stocks
Sub-total: Last week: -4.3%; +25.9% YTD
Grand Total:
- Portfolio Performance Last Week: -1.5%; YTD: +8.0%
In comparison, the A Potential "Multi-bagger" Portfolio of 10 stocks with market capitalizations between US$100M and US$399M was DOWN 3.5% last week but is still UP 16.5% YTD.
More By This Author:
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
Largest American Cannabis MSOs -3% This Week; Now Only +0.6% YTD
Largest Cannabis LPs -2% This Week; +10.5% YTD
Visit munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample more